These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase. Prince AM, Scheffel JW, Moore B. Transfusion; 1997 Feb; 37(2):211-4. PubMed ID: 9051098 [Abstract] [Full Text] [Related]
4. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy]. Kusendová K, Gavorník P, Sabaka P, Sviteková K. Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232 [Abstract] [Full Text] [Related]
5. Performance of three generations of anti-hepatitis C virus enzyme-linked immunosorbent assays in donors and patients. Vrielink H, Reesink HW, van den Burg PJ, Zaaijer HL, Cuypers HT, Lelie PN, van der Poel CL. Transfusion; 1997 Aug; 37(8):845-9. PubMed ID: 9280331 [Abstract] [Full Text] [Related]
6. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Mathiesen UL, Karlsson E, Foberg U, Frydén A, Franzén L, Widell A, Bodemar G. Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744 [Abstract] [Full Text] [Related]
7. Hepatitis C virus antibodies and virus replication in asymptomatic blood donors. Yuki N, Hayashi N, Hagiwara H, Naito M, Ohkawa K, Kasahara A, Fusamoto H, Ohtani S, Okubo Y, Kamada T. Vox Sang; 1994 Jul; 67(3):280-5. PubMed ID: 7532341 [Abstract] [Full Text] [Related]
8. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT, Wang TH, Sheu JC, Tsai SJ, Hsieh YS, Lin DT, Wang CY, Chen DS. Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269 [Abstract] [Full Text] [Related]
9. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR. Tucker TJ, Voigt M, Bird A, Robson S, Gibbs B, Kannemeyer J, Galloway M, Kirsch RE, Smuts H. S Afr Med J; 1997 May; 87(5):603-5. PubMed ID: 9254818 [Abstract] [Full Text] [Related]
10. Hepatitis C virus infection in Italian patients with hypogammaglobulinemia. Quinti I, Pandolfi F, Paganelli R, Giovannetti A, Sacco G, Oliva A, Aiuti F. Clin Ther; 1996 May; 18 Suppl B():96-107. PubMed ID: 8930447 [Abstract] [Full Text] [Related]
11. Testing of corneoscleral discs and their culture media of seropositive donors for hepatitis B and C virus genomes. Sengler U, Reinhard T, Adams O, Gerlich W, Sundmacher R. Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):783-7. PubMed ID: 11760041 [Abstract] [Full Text] [Related]
12. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay. Fabrizi F, de Vecchi AF, Como G, Lunghi G, Martin P. Aliment Pharmacol Ther; 2005 Apr 01; 21(7):861-9. PubMed ID: 15801921 [Abstract] [Full Text] [Related]
13. Impact of screening blood donors for hepatitis C antibody on posttransfusion hepatitis: a prospective study with a second-generation anti-hepatitis C virus assay. Huang YY, Yang SS, Wu CH, Shih WS, Huang CS, Chen PH, Lin YM, Shen CT, Chen DS. Transfusion; 1994 Aug 01; 34(8):661-5. PubMed ID: 7521077 [Abstract] [Full Text] [Related]
14. Clinical and virologic features of hepatitis C virus infection associated with intravenous immunoglobulin. Jonas MM, Baron MJ, Bresee JS, Schneider LC. Pediatrics; 1996 Aug 01; 98(2 Pt 1):211-5. PubMed ID: 8692620 [Abstract] [Full Text] [Related]
15. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW. N Engl J Med; 1996 Jun 27; 334(26):1691-6. PubMed ID: 8637513 [Abstract] [Full Text] [Related]
16. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting. Roth WK, Weber M, Seifried E. Lancet; 1999 Jan 30; 353(9150):359-63. PubMed ID: 9950441 [Abstract] [Full Text] [Related]
17. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Barrera JM, Bruguera M, Ercilla MG, Sánchez-Tapias JM, Gil MP, Costa J, Gelabert A, Rodés J, Castillo R. Ann Intern Med; 1991 Oct 15; 115(8):596-600. PubMed ID: 1909848 [Abstract] [Full Text] [Related]
18. Epidemiology, serological markers, and hepatic disease of anti-HCV ELISA-2-positive blood donors. Salmerón FJ, Palacios A, Pérez-Ruiz M, Torres C, Oyonarte S, Fernández-Montoya A, Ruiz-Extremera A. Dig Dis Sci; 1996 Oct 15; 41(10):1933-8. PubMed ID: 8888703 [Abstract] [Full Text] [Related]
19. Routine HCV PCR screening of blood donations to identify early HCV infection in blood donors lacking antibodies to HCV. Hitzler WE, Runkel S. Transfusion; 2001 Mar 15; 41(3):333-7. PubMed ID: 11274586 [Abstract] [Full Text] [Related]
20. Limited utility of alanine aminotransferase screening of hepatitis C antibody-screened blood donors. Cable R, Badon S, Pray C, Popovsky MA. Transfusion; 1997 Feb 15; 37(2):206-10. PubMed ID: 9051097 [Abstract] [Full Text] [Related] Page: [Next] [New Search]